BluePrint Research Group is a global commercial strategy consultancy founded in 2008. We partner with global life sciences decision makers to shape and inform go-to market strategy for the industry’s emerging innovative products, impacting and improving global health and wellness. Our blend of manufacturing and commercial side experience, as well as diversity of academic backgrounds, offer a unique perspective and allows us to develop customized deliverables to meet the needs of a diverse array of internal stakeholders. Our clients describe the work we do at BluePrint as profoundly strategic, providing highly actionable insights and recommendations and bringing singular clarity to complex situations. We take pride in our talented consulting teams across our seven global offices in Princeton, New York, San Francisco, Cambridge, Philadelphia, London & New Delhi. Over the past 12+ years, we have built our firm to 95+ employees, partnering with 55+ pharma, biopharma & medtech clients per year. More than 60% of our work is global, and our reach includes Europe, Latin American, Canada, Asia Pacific, and the Middle East. At BluePrint, innovation has always been a core value within our organization. Through our innovation lab and company-wide initiatives, we are continuing to expand our suite of products and services that enable us to deepen and broaden our impact with clients in informing commercial strategy, while also diversifying the learning and experience of our employees.